Showing results (961-970 of 1,284) with videos related to

Sort By:
Pageof 129
American Journal of Clinical Oncology|April 1, 2008
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumorsSteven J Cohen, Paul F Engstrom, Nancy L Lewis, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2015
Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignanciesMargaret von Mehren, Michael Bookman, Neal J Meropol, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|September 2, 2022
Foraminifera as a model of the extensive variability in genome dynamics among eukaryotesEleanor J Goetz, Mattia Greco, Hannah B Rappaport, et al.
Medical Oncology (Northwood, London, England)|November 20, 1998
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferonR K Alpaugh, M von Mehren, I Palazzo, et al.
Biochemical Pharmacology|March 24, 2004
Pharmacology of polymorphic variants of the human 5-HT1A receptorAndria L Del Tredici, Hans H Schiffer, Ethan S Burstein, et al.
Journal of Clinical Monitoring and Computing|November 10, 2020
Using near-infrared spectroscopy myocardial oximetry to monitor myocardial oxygen balance in a swine model of cardiac surgery: a descriptive studyRafael Honikman, Amit A Pawale, Shinobu Itagaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1993
Binding and cytotoxicity characteristics of the bispecific murine monoclonal antibody 2B1L M Weiner, M Holmes, A Richeson, et al.
Annals of Clinical and Translational Neurology|October 19, 2016
Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and ADDuygu Tosun, Norbert Schuff, Gil D Rabinovici, et al.
Pageof 129